Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
In BriefThis Month in JNM

This Month in JNM

Journal of Nuclear Medicine March 2011, 52 (3) 11A-12A;
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 52 no. 3 11A-12A

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online February 22, 2011.

Copyright & Usage 
© 2011 by Society of Nuclear Medicine

Author Information

Statistics from Altmetric.com

Cited By...

  • 1087 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: February 2011 to April 2025

AbstractFullPdf
Feb 201103368
Mar 2011080117
Apr 201101412
May 20110619
Jun 2011002
Jul 2011093
Aug 2011052
Sep 20110214
Oct 20110194
Nov 20110125
Dec 20110176
Jan 20120712
Feb 20120912
Mar 2012077
Apr 20120117
May 20120118
Jun 20120105
Jul 2012049
Aug 2012054
Sep 20120122
Oct 2012077
Nov 20120121
Dec 2012061
Jan 2013091
Feb 20130224
Mar 2013056
Apr 2013087
May 20130247
Jun 20130154
Jul 2013024
Aug 20130121
Sep 2013034
Oct 2013055
Nov 2013042
Dec 2013014
Jan 2014012
Feb 2014017
Mar 2014053
Apr 2014024
May 2014054
Jun 2014011
Jul 2014022
Aug 2014090
Sep 20140110
Oct 20140102
Nov 2014014
Dec 2014040
Jan 20150217
Feb 2015093
Mar 20150100
Apr 2015032
May 2015061
Jun 2015001
Jul 2015025
Aug 20150632
Sep 2015032
Oct 2015011
Nov 2015094
Dec 20150128
Jan 2016090
Feb 2016084
Mar 20160211
Apr 2016003
May 2016045
Jun 2016011
Jul 2016011
Aug 2016010
Sep 2016042
Oct 2016035
Nov 2016032
Dec 2016027
Jan 2017054
Feb 2017031
Mar 2017034
Apr 2017071
May 2017062
Jun 2017081
Jul 2017082
Aug 2017070
Sep 2017012
Oct 2017020
Nov 2017001
Dec 2017061
Jan 2018005
Feb 2018031
Mar 2018013
Apr 2018051
May 2018041
Jun 2018031
Sep 2018001
Dec 2018020
Feb 2019011
May 2019011
Jun 2019003
Jul 2019010
Aug 2019020
Sep 2019030
Nov 2019001
Dec 2019002
Jan 2020025
Mar 2020002
Apr 2020001
May 2020002
Jun 2020002
Jul 2020010
Aug 2020031
Sep 2020051
Oct 2020002
Nov 2020023
Dec 2020026
Jan 2021020
Feb 2021040
Mar 2021065
Apr 2021020
May 2021030
Jun 2021020
Jul 2021043
Aug 2021032
Sep 2021010
Oct 2021021
Nov 2021020
Dec 2021051
Jan 2022020
Feb 2022021
Mar 2022031
Apr 2022020
May 2022041
Jun 2022025
Jul 20220381
Aug 2022060
Sep 2022020
Oct 2022011
Nov 2022030
Dec 2022021
Jan 2023061
Feb 2023070
Mar 2023065
Apr 20230150
May 2023043
Jun 2023020
Jul 2023089
Aug 2023014
Nov 2023061
Dec 2023082
Jan 2024020
Feb 2024020
Mar 2024010
Apr 2024084
May 20240120
Jun 20240114
Jul 20240384
Aug 20240446
Sep 20240106
Oct 20240112
Nov 2024021
Dec 2024051
Jan 2025021
Feb 2025061
Mar 2025037
Apr 20250109
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 52 (3)
Journal of Nuclear Medicine
Vol. 52, Issue 3
March 1, 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
This Month in JNM
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
This Month in JNM
Journal of Nuclear Medicine Mar 2011, 52 (3) 11A-12A;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
This Month in JNM
Journal of Nuclear Medicine Mar 2011, 52 (3) 11A-12A;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • ON THE COVER
  • Info & Metrics
  • PDF

Related Articles

  • Transport of Selected PET Radiotracers by Human P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2): An In Vitro Screening
  • Recording Intracellular Molecular Events from the Outside: Glycosylphosphatidylinositol-Anchored Avidin as a Reporter Protein for In Vivo Imaging
  • Shortened Acquisition Protocols for the Quantitative Assessment of the 2-Tissue-Compartment Model Using Dynamic PET/CT 18F-FDG Studies
  • Molecular Design and Optimization of 99mTc-Labeled Recombinant Affibody Molecules Improves Their Biodistribution and Imaging Properties
  • Observation of Glucose Metabolism in the Thalamic Nuclei by Fusion PET/MRI
  • Micro-SPECT/CT–Based Pharmacokinetic Analysis of 99mTc-Diethylenetriaminepentaacetic Acid in Rats with Blood–Brain Barrier Disruption Induced by Focused Ultrasound
  • The Sentinel Node Procedure in Breast Cancer: Nuclear Medicine as the Starting Point
  • Preliminary Study of 11C-Choline PET/CT for T Staging of Locally Advanced Nasopharyngeal Carcinoma: Comparison with 18F-FDG PET/CT
  • In Vivo Imaging of Mineral Deposition in Carotid Plaque Using 18F-Sodium Fluoride PET/CT: Correlation with Atherogenic Risk Factors
  • Radiation Dosimetry of 82Rb in Humans Under Pharmacologic Stress
  • Detection and Characterization of Tumor Changes in 18F-FDG PET Patient Monitoring Using Parametric Imaging
  • 18F-FDG PET/CT for Early Response Assessment in Diffuse Large B-Cell Lymphoma: Poor Predictive Value of International Harmonization Project Interpretation
  • Total Abdominal 18F-FDG Uptake Reflects Intestinal Adenoma Burden in Apc Mutant Mice
  • In Vitro and In Vivo Evaluation of 64Cu-Labeled SarAr-Bombesin Analogs in Gastrin-Releasing Peptide Receptor–Expressing Prostate Cancer
  • Avoiding Barriers to PET Radioligand Development: Cellular Assays of Brain Efflux Transporters
  • Molecular Imaging in Radiotherapy Planning for Head and Neck Tumors
  • Intratumor Heterogeneity Characterized by Textural Features on Baseline 18F-FDG PET Images Predicts Response to Concomitant Radiochemotherapy in Esophageal Cancer
  • Accuracy and Reproducibility of Absolute Quantification of Myocardial Focal Tracer Uptake from Molecularly Targeted SPECT/CT: A Canine Validation
  • Monitoring Tumor Response to Antiangiogenic Sunitinib Therapy with 18F-Fluciclatide, an 18F-Labeled αVβ3-Integrin and αVβ5-Integrin Imaging Agent
  • PET of αvβ3-Integrin and αvβ5-Integrin Expression with 18F-Fluciclatide for Assessment of Response to Targeted Therapy: Ready for Prime Time?
  • Improvement in Lesion Detection with Whole-Body Oncologic Time-of-Flight PET
  • Dual-Biomarker Imaging of Regional Cerebral Amyloid Load and Neuronal Activity in Dementia with PET and 11C-Labeled Pittsburgh Compound B
  • 18F-Fluromisonidazole PET Imaging as a Biomarker for the Response to 5,6-Dimethylxanthenone-4-Acetic Acid in Colorectal Xenograft Tumors
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • This Month in JNM
  • This Month in JNM
  • This Month in JNM
Show more This Month in JNM

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire